Page last updated: 2024-10-24

regulation of dendritic cell cytokine production

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate, or extent of dendritic cell cytokine production. [GOC:add]

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that play a crucial role in initiating and shaping immune responses. Their ability to produce a diverse array of cytokines is essential for fine-tuning the immune response, determining whether an immune response is initiated, the type of response generated (e.g., Th1, Th2, or Th17), and the subsequent effector functions of other immune cells. The regulation of DC cytokine production is a complex process involving a variety of stimuli, signaling pathways, and transcription factors.

Upon encountering pathogens or danger signals, DCs undergo a process called maturation, which is characterized by changes in their morphology, surface marker expression, and cytokine production profile. Maturation triggers the production of a specific set of cytokines, such as IL-12, TNF-α, and IL-6, which contribute to the activation and polarization of T cells.

The regulation of DC cytokine production is tightly controlled by a complex network of signaling pathways. Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns (PAMPs) and activate downstream signaling cascades that involve MyD88, TRIF, and NF-κB pathways. These pathways ultimately lead to the transcription of genes encoding pro-inflammatory cytokines.

Cytokine receptors, such as IFN-α/β receptor and IL-10 receptor, also play a crucial role in regulating DC cytokine production. IFN-α/β, produced by infected cells, can activate STAT1 and induce the expression of genes involved in antiviral responses, such as IL-12 and IFN-β. IL-10, an anti-inflammatory cytokine, can suppress DC maturation and cytokine production through STAT3 signaling.

Transcription factors, such as NF-κB, AP-1, and STATs, are key regulators of DC cytokine production. These transcription factors bind to specific DNA sequences in the promoter regions of cytokine genes, controlling their expression levels. The activation and inhibition of these transcription factors are regulated by various signaling pathways and environmental cues.

The production of cytokines by DCs is also influenced by the surrounding microenvironment. The presence of other immune cells, such as T cells and NK cells, can influence DC cytokine production through cell-cell interactions and cytokine signaling. For example, T cells can produce IFN-γ, which can enhance IL-12 production by DCs.

In addition to these regulatory mechanisms, the epigenetic landscape, including DNA methylation and histone modifications, can also modulate DC cytokine production. These epigenetic modifications can influence the accessibility of cytokine gene promoters to transcription factors.

The intricate regulation of DC cytokine production ensures that immune responses are appropriately tailored to the specific threat encountered. By controlling the production of cytokines, DCs play a critical role in shaping the adaptive immune response and maintaining immune homeostasis.'
```"

Proteins (2)

ProteinDefinitionTaxonomy
Toll-like receptor 9A Toll-like receptor 9 that is encoded in the genome of human. []Homo sapiens (human)
Toll-like receptor 4A Toll-like receptor 4 that is encoded in the genome of human. [PRO:CNA, UniProtKB:O00206]Homo sapiens (human)

Compounds (6)

CompoundDefinitionClassesRoles
carvedilolcarbazoles;
secondary alcohol;
secondary amino compound
alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
hydroxychloroquinehydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
aminoquinoline;
organochlorine compound;
primary alcohol;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
dermatologic drug
methotrexatedicarboxylic acid;
monocarboxylic acid amide;
pteridines
abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
parthenolidesesquiterpene lactonedrug allergen;
inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
resatorvid
crx-526CRX-526: aminoalkyl-glucosaminide-phosphate; lipid A-mimetic with anti-inflammatory properties; structure in first source